UCLA study is the first to evaluate the drug, ibudilast, as a treatment for alcoholism. Study participants were given either the drug (20 milligrams for two days and 50 milligrams for the next four) or a placebo for six consecutive days.
After about a two-week break, those who took the drug were switched to a placebo for six days, and those who were taking the placebo were given ibudilast.
The researchers found that the subjects’ craving for alcohol was significantly lower when they were taking the medication.
In addition, the participants’ reactions were measured after they were asked to hold and smell a glass of their preferred alcoholic beverage but not allowed to drink it.
The subjects reported being in a better mood while they were taking ibudilast than when they were on the placebo.
Full Story, click here
Main site, click here